Microglial Metabolic Reconfiguration Provides a New Strategy for the Treatment of Alzheimer's Disease
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Wu S, Kersten S, Qi L
. Lipoprotein Lipase and Its Regulators: An Unfolding Story. Trends Endocrinol Metab. 2020; 32(1):48-61.
PMC: 8627828.
DOI: 10.1016/j.tem.2020.11.005.
View
2.
Payne J, Maher F, Simpson I, Mattice L, Davies P
. Glucose transporter Glut 5 expression in microglial cells. Glia. 1997; 21(3):327-31.
DOI: 10.1002/(sici)1098-1136(199711)21:3<327::aid-glia7>3.0.co;2-1.
View
3.
Scacchi R, Gambina G, Broggio E, Moretto G, Ruggeri M, Corbo R
. The H+ allele of the lipoprotein lipase (LPL) HindIII intronic polymorphism and the risk for sporadic late-onset Alzheimer's disease. Neurosci Lett. 2004; 367(2):177-80.
DOI: 10.1016/j.neulet.2004.05.111.
View
4.
Leng L, Yuan Z, Pan R, Su X, Wang H, Xue J
. Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance. Nat Metab. 2022; 4(10):1287-1305.
DOI: 10.1038/s42255-022-00643-4.
View
5.
Colonna M, Butovsky O
. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol. 2017; 35:441-468.
PMC: 8167938.
DOI: 10.1146/annurev-immunol-051116-052358.
View